Waddell & Associates, LLC Ionis Pharmaceuticals Inc Transaction History

Waddell & Associates, LLC

  • $815 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
BUY
$31.71 - $43.0 $318,431 - $431,806
10,042 New
10,042 $372,000
Q3 2021

Nov 10, 2021
SELL
$33.54 - $40.55 $336,808 - $407,203
-10,042 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$34.54 - $47.25 $346,850 - $474,484
10,042 New
10,042 $401,000

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Waddell & Associates, LLC Portfolio

Follow Waddell & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waddell & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waddell & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email